ACWM
GSK icon

Adams Chetwood Wealth Management’s GSK GSK Stock Holding History

Adams Chetwood Wealth Management’s Portfolio GSK Stock Details GSK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q4 		– Sell
-10,226
Closed -$481K – 77
2020
Q3 		$481K Sell
10,226
-1,840
-15% -$92.2K 0.46% 44
2020
Q2 		$615K Hold
12,066
– – 0.63% 35
2020
Q1 		$632K Buy
12,066
+337
+3% +$18K 0.74% 31
2019
Q4 		$689K Buy
+11,729
New +$652K 0.7% 26

Other funds holding GSK

Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Hotchkis & Wiley Capital Management
Hotchkis & Wiley Capital Management Los Angeles, California $32.4B AUM 17.21% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
BCIM
Black Creek Investment Management Toronto, Ontario, Canada $1.86B AUM 15.33% 1-Year Est. Return

Adams Chetwood Wealth Management's GSK Position: Q4 2020 in Review

Adams Chetwood Wealth Management sold out of GSK (GSK) in Q4 2020, closing a stake of 10,226 shares — an estimated $481K sold.

Adams Chetwood Wealth Management first reported a position in GSK in Q4 2019 and held it in 4 quarters. The position peaked at $689K in Q4 2019. 818 funds tracked by Wall St. Rank hold GSK as of Q4 2020.

  • Adams Chetwood Wealth Management reported no remaining GSK position as of Q4 2020 after selling out during the quarter.
  • Adams Chetwood Wealth Management sold 10,226 GSK shares in Q4 2020, an estimated $481K.
  • Adams Chetwood Wealth Management first reported a position in GSK in Q4 2019 and held it in 4 quarters.
  • Adams Chetwood Wealth Management's GSK position peaked at $689K in Q4 2019.
  • 818 funds tracked by Wall St. Rank held GSK as of Q4 2020.

Based on Adams Chetwood Wealth Management's 13F filing for Q4 2020, filed 29 Jan 2021.